Lilly Diabetes
Hospitals & Physicians Clinics · India · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ind, Himachal Pradesh, IndiaWebsite
www.lillydiabetes.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
3
1
2
3
1
About Lilly Diabetes
Eli Lilly and Company specializes in diabetes management, offering resources and support to help individuals actively manage their condition through medical treatment and lifestyle changes. The company provides information on different types of diabetes, treatment options, and access to diabetes specialists, both in-person and virtually. Their services are aimed at the over 800 million people worldwide living with diabetes, including those diagnosed with Type 1, Type 2, and gestational diabetes. Additionally, Lilly emphasizes the importance of overall well-being, providing science-backed resources on various health aspects related to diabetes management.Explore more
Lilly Diabetes Org Chart
DL
Sales Specialist
KR
Senior Sales Representative
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lilly Diabetes your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Lilly Diabetes has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Lilly Diabetes
Lilly Diabetes, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Lilly Diabetes recently announced quarterly report
Product Launch: Get notified when Lilly Diabetes launches new products
Click to see if Lilly Diabetes had a recent Job posting/layoffs
Check out if Lilly Diabetes is spiking on competitors!
Funding: Get notified immidiatlly once Lilly Diabetes has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Lilly Diabetes as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Lilly Diabetes is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Lilly Diabetes is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Lilly Diabetes.
Lilly Diabetes Tech Stack
A closer look at the technologies used by Lilly Diabetes
Lilly Diabetes News & Media
Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease
The U.S. Food and Drug Administration (FDA) has approved Trulicity® (dulaglutide) for the reduction of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who have established cardiovascular (CV) disease or multiple cardiovascular risk factors. This decision makes Eli Lilly and Company's (NYSE: LLY) Trulicity the first and only type 2 diabetes medicine approved to reduce the risk of MACE for both primary and secondary prevention populations.*Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
INDIANAPOLIS, Jan. 28, 2020 /PRNewswire/ -- Starting this month, Eli Lilly and Company (NYSE: LLY) will donate at least 200,000 KwikPens® to three relief organizations – Americares, Direct Relief and Dispensary of Hope – to stock insulin at nearly 200 U.S. free clinics through 2022. These...Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Starting this month, Eli Lilly and Company (NYSE: LLY) will donate at least 200,000 KwikPens® to three relief organizations – Americares, Direct Relief and Dispensary of Hope – to stock insulin at nearly 200 U.S. free clinics through 2022. These donations will directly support lower-income people living with diabetes who qualify for free clinic services.Lilly expands insulin affordability options with lower-priced versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen®
INDIANAPOLIS, Jan. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin by introducing lower-priced versions of Humalog® Mix75/25™ KwikPen® (insulin lispro protamine...
Read more news
Top Hospitals & Physicians Clinics Companies
Frequently Asked Questions Regarding Lilly Diabetes
Sign Up For FreeTo access detailed company insights
Eli Lilly and Company specializes in diabetes management, offering resources and support to help individuals actively manage their condition through medical treatment and lifestyle changes. The company provides information on different types of diabetes, treatment options, and access to diabetes specialists, both in-person and virtually. Their serv... Read More
